vTv Therapeutics (VTVT) Non Operating Interest Expenses (2014 - 2023)

vTv Therapeutics has disclosed Non Operating Interest Expenses across 10 years of filings, most recently posting $7000.0 for Q4 2023.

• In Q4 2023, Non Operating Interest Expenses rose 16.67% year-over-year to $7000.0; the TTM figure through Dec 2023 stood at $13000.0 (down 13.33% YoY), while the FY2023 annual figure was $13000.0, down 13.33% from the prior year.
• Non Operating Interest Expenses came in at $7000.0 for Q4 2023 at vTv Therapeutics, up from $4000.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $626000.0 in Q1 2019 to a low of $1000.0 in Q1 2022.
• Average Non Operating Interest Expenses over 5 years is $159937.5, with a median of $37500.0 recorded in 2020.
• Year-over-year, Non Operating Interest Expenses plunged 97.45% in 2021 and surged 33.33% in 2022.
• Over 5 years, Non Operating Interest Expenses stood at $283000.0 in 2019, then plunged by 76.33% to $67000.0 in 2020, then slumped by 91.04% to $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then grew by 16.67% to $7000.0 in 2023.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $7000.0 in Q4 2023, $4000.0 in Q3 2023, and $2000.0 in Q2 2023.